BC
Bellco Capital
Private EquityModerateBellco Capital is a private equity firm based in Los Angeles, California.
5
Investments
3
Exits
—
AUM
60.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Bellco Capital.
Investment Thesis & Strategy
Bellco Capital, as a private equity firm, invests in various stages of fintech companies, likely seeking established businesses with strong growth potential and the ability to generate significant returns.
Investment Activity
Deals per year over the last 12 years
2
20100
20111
20121
20134
20141
20152
20160
20170
20180
20190
20201
2021Portfolio Companies
Selected investments from their portfolio of 5 companies
V
Ventyx Biosciences
Biotech · Series A, 2021
O
Obsidian Therapeutics
Biotech · Series A, 2016
R
Rapt Therapeutics
Biotech · Series A, 2016
R
Revolution Medicines
Biotech · Series A, 2015
T
Turning Point Therapeutics
Biotech · Series A, 2014
P
Poseida Therapeutics
Biotech · Series A, 2014
K
Kura Oncology
Biotech · Series A, 2014
C
Cidara Therapeutics
Biotech · Series A, 2014
A
Aeglea BioTherapeutics
Biotech · Series A, 2013
P
Protagonist Therapeutics
Biotech · Series A, 2012
M
Mirati Therapeutics
Biotech · Series A, 2010
A
Acacia Pharma
Healthcare · Series A, 2010
Frequently Asked Questions
Bellco Capital focuses on Series B, Series C+ stage investments.
Related Investors
Kayne Partners
Los Angeles, United States · 36 deals
Angeleno Group
Los Angeles, United States · 29 deals
Palisades Growth Capital
Los Angeles, United States · 28 deals
AGO Partners
Los Angeles, United States · 26 deals
3L Capital
Los Angeles, United States · 21 deals
Shamrock Capital Advisors
Los Angeles, United States · 21 deals